
Pergocoat Film-Coated Tablet for Horses
Pergocoat Film-Coated Tablet for Horses
Symptomatic treatment of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) (Equine Cushing's Disease).
Pharmaceutical form:
- Pergocoat 0.5 mg film-coated tablets for horses: Off-white sphere shaped, film-coated tablet
- Pergocoat 1 mg film-coated tablets for horses: Beige sphere shaped, film-coated tablet
The horse must have been declared as not intended for human consumption under national horse passport legislation.
Not authorised for use in mares producing milk for human consumption.
Store in the original package, in order to protect from light.
For animal treatment only. To be supplied only on veterinary prescription. Keep out of the sight and reach of children.
- Do not use in horses with known hypersensitivity to pergolide mesilate or other ergot derivatives or to any of the excipients
- Do not use in horses less than 2 years of age
- This product may cause hypersensitivity (allergy) reactions. People with known hypersensitivity to pergolide or other ergot derivatives should avoid contact with the veterinary medicinal product.
- Accidental ingestion, especially by children, may cause adverse reactions such as emesis, dizziness, lethargy or low blood pressure. To avoid accidental ingestion, the blister should be replaced into the carton and carefully kept away from children. Avoid hand-to-mouth contact. Do not eat, drink or smoke when using this product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
- This product may cause eye irritation. Avoid contact with the eyes including hand-to-eye contact when handling the tablets. Minimize exposure risks when dissolving the tablets, e.g. tablets should not be crushed. In case of contact of the dissolved product with skin, wash exposed skin with water. In the event of eye exposure, flush the affected eye immediately with water and seek medical advice.
- Wash hands after use.